Cocaine treatment increases expression of a 40 kDa catecholamine-regulated protein in discrete brain regions

Synapse

Volumn 47, Issue 1, 2003, Pages 33-44

  Sharan, Niki ^a   Chong, Victor Z ^a   Nair, Venugopalan D ^b   Mishra, Ram K ^a   Hayes, Robert J ^b   Gardner, Eliot L ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Anisomycin; Dopamine; Free radicals; Neuroprotection; Oxidative stress; Spin trapping agent

Indexed keywords

ANISOMYCIN; BRAIN PROTEIN; C REACTIVE PROTEIN; CATECHOLAMINE; COCAINE; DOPAMINE; FREE RADICAL; HEAT SHOCK PROTEIN 70; ISOPROTEIN; N TERT BUTYL ALPHA PHENYLNITRONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENUATION; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; EXTRACELLULAR SPACE; MALE; MEDULLA OBLONGATA; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RAT; SPIN TRAPPING; UPREGULATION;

ANIMALS; ANISOMYCIN; BLOTTING, WESTERN; BRAIN; COCAINE; CORPUS STRIATUM; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EXTRACELLULAR SPACE; FREE RADICAL SCAVENGERS; HSP70 HEAT-SHOCK PROTEINS; MALE; MEDULLA OBLONGATA; NERVE TISSUE PROTEINS; NEUROPROTECTIVE AGENTS; NITROGEN OXIDES; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0037211853     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10140     Document Type: Article

References (45)

1. Amara SG, Arriza JL. 1993. Neurotransmitter transporters: Three distinct gene families. Curr Opin Neurobiol 3:337-344.
2. Bannon MJ, Wolf ME, Roth RH. 1983. Pharmacology of dopamine neurons innervating the prefrontal, cingulate and piriform cortices. Eur J Pharmacol 92:119-125.
3. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
4. Cass WA, Gerhardt GA, Mayfield RD, Curella P, Zahniser NR. 1992. Differences in dopamine clearance and diffusion in rat striatum and nucleus accumbens following systemic cocaine administration. J Neurochem 59:259-266.
5. Chen G, Griffin M, Poyer JL, McCay PB. 1990. HPLC procedure for the pharmacokinetic study of the spin-trapping agent, alpha-phenyl-N-tert-butyl nitrone (PBN). Free Radic Biol Med 9:93-98.
6. Colado MI, Green AR. 1995. The spin trap reagent alpha-phenyl-N tert-butyl nitrone prevents 'ecstasy'-induced neurodegeneration of 5-hydroxytryptamine neurones. Eur J Pharmacol 280:343-346.
7. Di Bello MG, Masini E, Ioannides C, Fomusi NJ, Raspanti S, Bani ST, Mannaioni PF. 1998. Histamine release from rat mast cells induced by the metabolic activation of drugs of abuse into free radicals. Inflamm Res 47:122-130.
8. Di Chiara G, Imperato A. 1988. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85:5274-5278.
9. Floyd RA. 1999. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med 222:236-245.
10. Floyd RA, West M, Hensley K. 2001. Oxidative biochemical markers; clues to understanding aging in long-lived species. Exp Gerontol 36:619-640.
11. Gardner EL. 2000. What we have learned about addiction from animal models of drug self-administration. Am J Addict 9:285-313.
12. Gardner EL, Ashby CR. 2000. Heterogeneity of the mesotelencephalic dopamine fibers: Physiology and pharmacology. Neurosci Biobehav Rev 24:115-118.
13. Rev 24:115-118. Goto A, Doering L, Nair VD, Mishra RK. 2001. Immunohistochemical localization of a 40-kDa catecholamine regulated protein in the nigrostriatal pathway. Brain Res 900:314-319.
14. Henry DJ, White FJ. 1991. Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens. J Pharmacol Exp Ther 258:882-890.
15. Hirata H, Asanuma M, Cadet JL. 1998. Melatonin attenuates methamphetamine-induced toxic effects on dopamine and serotonin terminals in mouse brain. Synapse 30:150-155.
16. Horn AS. 1990. Dopamine uptake: A review of progress in the last decade. Prog Neurobiol 34:387-400.
17. 3H]dopamine uptake in vitro in rat nucleus accumbens but not in striatum. Brain Res 531:338-341.
18. Kloss MW, Rosen GM, Rauckman EJ. 1984. Biotransformation of norcocaine to norcocaine nitroxide by rat brain microsomes. Psychopharmacology (Berl) 84:221-224.
19. Koob GF. 1992. Drugs of abuse: Anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13:177-184.
20. Koob GF, Bloom FE. 1988. Cellular and molecular mechanisms of drug dependence. Science 242:715-723.
21. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
22. Maisonneuve IM, Keller RW, Glick SD. 1990. Similar effects of D-amphetamine and cocaine on extracellular dopamine levels in medial prefrontal cortex of rats. Brain Res 535:221-226.
23. Modi PI, Kashyap A, Nair VD, Ross GM, Fu M, Savelli JE, Marcotte ER, Barlas C, Mishra RK. 1996. Modulation of brain catecholamine absorbing proteins by dopaminergic agents. Eur J Pharmacol 299:213-220.
24. Moghaddam B, Bunney BS. 1989. Differential effect of cocaine on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens: Comparison to amphetamine. Synapse 4:156-161.
25. Morgan AE, Porter SP, Clarkson FA, Volkow ND, Fowler JS, Dewey SL. 1997. Direct approach for attenuating cocaine's effects on extracellular dopamine: Targeting the dopamine transporter. Synapse 26:423-427.
26. Nair VD, Mishra RK. 2001. Molecular cloning, localization and characterization of a 40-kDa catecholamine-regulated protein. J Neurochem 76:1142-1152.
27. Nakao N, Brundin P. 1997. Effects of alpha-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionic acid. Neuroscience 76:749-761.
28. Nestler EJ, Terwilliger RZ, Walker JR, Sevarino KA, Duman RS. 1990. Chronic cocaine treatment decreases levels of the G protein subunits Gi alpha and Go alpha in discrete regions of rat brain. J Neurochem 55:1079-1082.
29. Paxinos G, Watson C. 1986. The Rat Brain in Stereotaxic Coordinates, 2nd Ed. Sydney: Academic Press.
30. Pettit HO, Pan HT, Parsons LH, Justice JB. 1990. Extracellular concentrations of cocaine and dopamine are enhanced during chronic cocaine administration. J Neurochem 55:798-804.
31. Phillips AG, Blaha CD, Fibiger HC. 1989. Neurochemical correlates of brain-stimulation reward measured by ex vivo and in vivo analyses. Neurosci Biobehav Rev 13:99-104.
32. Pierce RC, Kalivas PW. 1997. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 25:192-216.
33. Ross GM, McCarry BE, Mishra RK. 1995. Covalent affinity labeling of brain catecholamine-absorbing proteins using a high-specific-activity substituted tetrahydronaphthalene. J Neurochem 65:2783-2789.
34. Savelli JE, Chugh A, Cheng C, Mishra RK, Johnson RL. 1995. Modulation of N-methyl-D-aspartate (NMDA) antagonist-induced darting behaviour by the peptidomimetic PAMTA. Brain Res 682:41- 49.
35. Schafe GE, LeDoux JE. 2000. Memory consolidation of auditory pavlovian fear conditioning requires protein synthesis and protein kinase A in the amygdala. J Neurosci 20:RC96.
36. Self DW, Nestler EJ. 1995. Molecular mechanisms of drug reinforcement and addiction. Annu Rev Neurosci 18:463-495.
37. Sharan N, Nair VD, Mishra RK. 2001. Modulation of a 40-kDa catecholamine regulated protein by dopamine receptor antagonists. Eur J Pharmacol 413:73-79.
38. Striplin CD, Kalivas PW. 1992. Correlation between behavioral sensitization to cocaine and G protein ADP-ribosylation in the ventral tegmental area. Brain Res 579:181-186.
39. Striplin CD, Kalivas PW. 1993. Robustness of G protein changes in cocaine sensitization shown with immunoblotting. Synapse 14:10- 15.
40. Terwilliger RZ, Beitner-Johnson D, Sevarino KA, Crain SM, Nestler EJ. 1991. A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res 548:100-110.
41. Weiss F, Paulus MP, Lorang MT, Koob GF. 1992. Increases in extracellular dopamine in the nucleus accumbens by cocaine are inversely related to basal levels: Effects of acute and repeated administration. J Neurosci 12:4372-4380.
42. Wise RA, Bozarth MA. 1987. A psychomotor stimulant theory of addiction. Psychol Rev 94:469-492.
43. Woolverton WL, Johnson KM. 1992. Neurobiology of cocaine abuse. Trends Pharmacol Sci 13:193-200.
44. Zachor DA, Moore JF, Brezausek C, Theibert A, Percy AK. 2000. Cocaine inhibits NGF-induced PC12 cells differentiation through D(1)-type dopamine receptors. Brain Res 869:85-97.
45. Zimmerman EF, Potturi RB, Resnick E, Fisher JE. 1994. Role of oxygen free radicals in cocaine-induced vascular disruption in mice. Teratology 49:192-201.